Atlas Trials

A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

Clinical trial NCT00927823 · COMPLETED

Trial details

NCT number
NCT00927823
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2009-12-01
Primary completion
2011-03-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.